
Partnership with EUSA Pharma brings Caphosol for the prevention and treatment of cancer treatment – induced mucositis
In 2016, AxxessBio and EUSA Pharma entered into an exclusive agreement to supply Caphosol Solution and Caphosol Dispersible tablets in selected countries of Southeast Asia. Caphosol is a mouthwash indicated for the prevention and treatment of oral mucositis due to cancer chemotherapy or radiation. It is a supersaturated solution